MannKind Corporation (MNKD)

Etorro trading 970x250
MannKind Corporation (MNKD) Logo

About MannKind Corporation

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. The company offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity used for the treatment of hypothyroidism. The company has a license and collaboration agreement with United Therapeutics Corporation for the development and commercialization of a dry powder formulation of Treprostinil (Tyvaso DPI) used for the treatment of pulmonary arterial hypertension. MannKind Corporation was incorporated in 1991 and is headquartered in Westlake Village, California. Address: 30930 Russell Ranch Road, Westlake Village, CA, United States, 91362

MannKind Corporation News and around…

Latest news about MannKind Corporation (MNKD) common stock and company :

United Therapeutics' (UTHR) Tyvaso DPI NDA Gets CRL From FDA
19 Oct, 2021 Yahoo! Finance

United Therapeutics' (UTHR) new drug application for Tyvaso DPI to treat PAH & PH-ILD fails to secure approval from the FDA. The stock declines resultantly.

46 Biggest Movers From Yesterday
19 Oct, 2021 FinancialContent

Gainers Valneva SE (NASDAQ: VALN) shares surged 39.8% to close at $39.21 on Monday after the company reported VLA2001 met both ...

United Therapeutics hits speed bump in its quest for new drug approval
18 Oct, 2021 Yahoo! Finance

The company applied in April for Food and Drug Administration approval to sell the new product. Now that process could take a bit more time.

Mid-Afternoon Market Update: Dow Falls 70 Points; Evolving Systems Shares Spike Higher
18 Oct, 2021 FinancialContent

Toward the end of trading Monday, the Dow traded down 0.20% to 35,223.86 while the NASDAQ rose 0.68% to 14,998.54. The S&P also ...

Upcoming IPOs This Week: Vita Coco, Portillo’s and 8 More New Stocks to Watch
18 Oct, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips There's upcoming IPOs this week that traders are going to want to keep an eye on and we're helping out with a handy list for investors. The post Upcoming IPOs This Week: Vita Coco, Portillo’s and 8 More New Stocks to Watch appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

12 Health Care Stocks Moving In Monday's Intraday Session
18 Oct, 2021 FinancialContent

Gainers Progenity (NASDAQ:PROG) shares increased by 33.17% to $2.85 during Monday's regular session. As of 12:30 ...

Why Shares of MannKind Corporation Are Falling This Morning
18 Oct, 2021 FinancialContent

Investors are hyperventilating after a delay for its inhaled medicine.

Mid-Day Market Update: Nasdaq Rises 50 Points; Revance Therapeutics Shares Plummet
18 Oct, 2021 FinancialContent

Midway through trading Monday, the Dow traded down 0.05% to 35,275.96 while the NASDAQ rose 0.34% to 14,948.46. The S&P also rose, ...

34 Stocks Moving In Monday's Mid-Day Session
18 Oct, 2021 FinancialContent

Gainers Valneva SE (NASDAQ: VALN) shares jumped 34.6% to $37.75 after the company reported VLA2001 met both co-primary endpoints ...

Monday's ETF Movers: URA, XBI
18 Oct, 2021 FinancialContent

In trading on Monday, the Uranium ETF is outperforming other ETFs, up about 6.8% on the day. Components of that ETF showing particular strength include shares of Denison Mines, up about 14.3% and shares of Fission Uranium, up about 12.2% on the day.

The FuelCell Energy Chatter That Has FCEL Stock Trending Today
18 Oct, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips FuelCell Energy (FCEL) stock is on the move Monday despite a lack of news concerning the fuel cell development and manufacturing company. The post The FuelCell Energy Chatter That Has FCEL Stock Trending Today appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

MNKD Stock: The Disappointing FDA News That Has MannKind Shares Diving Today
18 Oct, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips MannKind (MNKD) stock is taking a beating on Monday after releasing an update to investors concerning news from the FDA for Tyvaso DPI. The post MNKD Stock: The Disappointing FDA News That Has MannKind Shares Diving Today appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

MannKind's stock falls 18% after FDA says it will not approve application for hypertension drug
18 Oct, 2021 Yahoo! Finance

Shares of MannKind Corp. tumbled 18.3% in trading on Monday after the company said the Food and Drug Administration would not approve a pulmonary arterial hypertension treatment it is developing with United Therapeutics Corp. . United's stock was down 2.6%. MannKind said in a news release that the FDA had issued a complete response letter to United Therapeutics, citing a problem with a third-party testing center for the substance used to make Tyvaso DPI. MannKind said it looks "forward to suppor

Why MannKind Shares Are Falling Today
18 Oct, 2021 FinancialContent

MannKind Corp (NASDAQ: MNKD) is trading significantly lower Monday morning after the companyannounced the FDA issued a complete ...

FDA Declines MannKind - United Therapeutics' Formulated Treprostinil For Lung Disease
18 Oct, 2021 FinancialContent

TheFDA has issued a complete responsetoUnited Therapeutics Corporation(NASDAQ: UTHR) regarding the marketing ...

12 Health Care Stocks Moving In Monday's Pre-Market Session
18 Oct, 2021 FinancialContent

Gainers Valneva (NASDAQ:VALN) stock increased by 35.65% to $38.05 during Monday's pre-market session. The market ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
18 Oct, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back, trader! I hope the weekend served you well because we've got pre-market stock movers to start off Monday with! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

UPDATE 1-U.S. FDA declines to approve United-Mannkind's lung disease therapy
18 Oct, 2021 Yahoo! Finance

The U.S. Food and Drug Administration has declined to approve a lung disease therapy developed by United Therapeutics and Mannkind Corp, citing an inspection issue at a third-party facility. United said on Monday the health regulator's draft label for the drug, Tyvaso DPI, includes its use as a treatment for pulmonary arterial hypertension (PAH), as well as PAH associated with interstitial lung disease (PH-ILD).

United Therapeutics, Mannkind Fall After FDA Declines to Approve Lung Drug
18 Oct, 2021 Yahoo! Finance

By Sam Boughedda

Progress Update on Tyvaso DPI™ New Drug Application
18 Oct, 2021 Yahoo! Finance

Complete response received by United Therapeutics cites an open inspection issue at a third-party analytical testing center; no other deficiencies citedNo issues identified regarding operations performed at MannKind’s manufacturing facility in Connecticut WESTLAKE VILLAGE, Calif. and DANBURY, Conn., Oct. 18, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orpha

Interesting MNKD Put And Call Options For December 17th
15 Oct, 2021 FinancialContent

Investors in MannKind Corp (MNKD) saw new options become available this week, for the December 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MNKD options chain for the new December 17th contracts and identified one put and one call contract of particular interest.

Noteworthy Tuesday Option Activity: LNG, DIS, MNKD
12 Oct, 2021 FinancialContent

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Cheniere Energy Inc. (LNG), where a total volume of 10,269 contracts has been traded thus far today, a contract volume which is representative of approximately 1.0 million underlying shares (given that every 1 contract represents 100 underlying shares)..

10 momentum stocks that are entering a favorable stage of the year
08 Oct, 2021 FinancialContent

Momentum stocks tend to be strongest in the last couple of months of the year and weakest in January.

MNKD November 26th Options Begin Trading
07 Oct, 2021 FinancialContent

Investors in MannKind Corp (MNKD) saw new options become available today, for the November 26th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MNKD options chain for the new November 26th contracts and identified one put and one call contract of particular interest.

Do Options Traders Know Something About MannKind (MNKD) Stock We Don't?
04 Oct, 2021 Yahoo! Finance

Investors need to pay close attention to MannKind (MNKD) stock based on the movements in the options market lately.

MannKind Announces First Patient Enrolled in INHALE-1 Study of Afrezza® in Pediatric Population
04 Oct, 2021 Yahoo! Finance

Multi-center study to assess the efficacy and safety of Afrezza in patients aged 4-17 living with type 1 or type 2 diabetesWESTLAKE VILLAGE, Calif., Oct. 04, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases, announced today the enrollment of the first pediatric patient in the INHALE-1 study. The multi-center study will evaluate the efficacy

5 Penny Stocks To Watch This Week With Potential Biotech Catalysts
03 Oct, 2021 FinancialContent
Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates
01 Oct, 2021 FinancialContent

Following a mixed month for regulatory approvals, biotech investors now turn toward a month of plenty as far as Food and Drug ...

Interesting MNKD Put Options For November 12th
30 Sep, 2021 FinancialContent

Investors in MannKind Corp (MNKD) saw new options become available today, for the November 12th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MNKD options chain for the new November 12th contracts and identified the following put contract of particular interest.

The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
30 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

MannKind Corporation (MNKD) is a NASDAQ Common Stock listed in , ,

970x250